What You Should Know

ALL is also called acute lymphocytic leukemia and acute lymphoid leukemia.

ALL affects the blood cells and immune system.

There are several ALL subtypes.

The type of treatment you receive and your treatment outcome depend on your ALL subtype and individual risk factors.

Most children with ALL are cured of their disease after treatment.

The numbers of adults and their remission lengths have grown significantly over the past 30 years.

What You Should Do

Choose a doctor who specializes in treating ALL. This type of specialist is called a hematologist-oncologist. Or, your local cancer specialist can work with a leukemia specialist.

Talk with your doctor about your diagnostic tests and what the results mean.

Talk with your doctor about all your treatment options and the results you can expect from treatment.

Obtain and keep records of your test results and the treatment you receive as this information is useful for long-term follow-up of your condition.

How Does ALL Develop?

ALL results from either an acquired or a genetic injury to the DNA (genetic material) of a developing stem cell in the bone marrow.

Stem cells form blood cells (white cells, red cells and platelets).

Although ALL starts in a stem cell in the bone marrow, it can spread to other areas such as the central nervous system, the lymph nodes and, more rarely, the testes.

This damaged cell becomes a leukemic cell and multiplies uncontrollably into billions of cells called leukemic lymphoblasts.

Leukemic lymphoblasts

Do not function normally

Block the production of normal cells

Grow and survive better than normal cells

As a result, the number of healthy blood cells (red cells, white cells and platelets) is usually lower than normal.

Anemia is a condition when there is a low number of red cells in the blood which can cause fatigue and shortness of breath.

Neutropenia is a condition when there is a low number of white cells so that the immune system can't effectively guard against infection due to a lack of neutrophils (a type of white cell).

Thrombocytopenia is a condition when there is a low number of platelets which can cause bleeding and easy bruising with no apparent cause.

Low numbers of all three blood cell counts is called pancytopenia.

Risk Factors

Doctors don't know why some cells become leukemic cells and others don't. For most people who have acute lymphoblastic leukemia (ALL), there are no obvious reasons why they developed the disease.

Risk factors associated with the disease include:

Exposure to high doses of radiation therapy (studied in survivors of atomic bomb detonations in Japan). A child exposed to multiple diagnostic x-rays may be at a slight increased risk of developing ALL, but further research is required to confirm these findings.

Previous exposure to chemotherapy and radiotherapy may cause ALL in adults.

Scientists continue to explore relationships between ALL and lifestyle or environmental factors. More developed countries and higher socioeconomic groups tend to have higher ALL rates.

Research supports the view that a number of complex factors are involved in the risk of developing ALL.

Currently, there's no way to prevent the disease. You can't catch ALL from someone else.

Prenatal Development

Some cases of ALL relate to a mutation in a lymphocyte that occurs during the prenatal period (in utero). The leukemia is usually diagnosed in infancy or the first few years after birth. However, years may pass before the disease appears. With ALL, it seems that additional genetic abnormalities can occur after birth and allow the unregulated cell growth that triggers the disease, because there are more mutations found in utero than there are cases of childhood ALL.

Follow us

Sign up for latest news

This field is requiredEmail address

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.